Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Company News
Events
Directory
Search
Close search
Home
Company
Structural Genomics Consortium
Structural Genomics Consortium
Activities:
Research & Development
X
LinkedIn
Trending Articles
Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222
Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
CordenPharma & GENEPEP collaborate to leverage peptide drug substance discovery
The partnership has facilitated the expedition of the development, discovery and manufacturing of peptides for early clinical phase
ISPE announces 2024 Facility of the Year Awards category winners
The awards programme recognises pharmaceutical companies that are the 'best' in the industry for innovation, operations, digitalisation, supply chain and social impact
Tabletability, compactability and compressibility: What’s the difference?
To patients and consumers, tablets are a simple and convenient dosage form, but the science behind compressing a block of particles or granules into a single tablet can be...
Chemistry, manufacturing and control (CMC) as key drivers for drug discovery success
Embracing collaborative strategies not only accelerates drug development programmes but also fosters science-based milestone decisions, mitigates risks and prepares for...
Upcoming event
Making Pharmaceuticals
23–24 April 2024 | Exhibition | Coventry, UK
See all
Related Content
Research & Development
Myeloma UK and the Structural Genomics Consortium link up to discover new drug targets for myeloma
The open-access collaboration will make all reagents and knowledge available to pharma, biotech and academic research groups
Research & Development
Takeda invests CA$7.5m in Structural Genomics Consortium to fund collective drug research
Renewing a partnership that started in 2012
Research & Development
Drug discovery: a job too complex for academia or industry alone?
<b>5 - 6 January 2012</b><br> <i>Two-day conference</i><br> Oxford, UK
Research & Development
SGC provides funding of US$49m to support drug discovery
Eli Lilly and Pfizer join the Structural Genomics Consortium
Subscribe now